five

Targeting IDH1 as a pro-senescent therapy in high-grade serous ovarian cancer. Targeting IDH1 as a pro-senescent therapy in high-grade serous ovarian cancer

收藏
NIAID Data Ecosystem2026-03-11 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA528523
下载链接
链接失效反馈
官方服务:
资源简介:
We found that targeting IDH1 in HGSC induces senescence by altering the repressive histone landscape of E2F target genes Overall design: Ovcar3 cells were infected with control or shIDH1. Cells were selected in 3ug/mL puromycin for 7 days. RNA was isolated and RNA-seq was performed comparing control and knockdown RNA.
创建时间:
2019-03-21
二维码
社区交流群
二维码
科研交流群
商业服务